PHF6
Basic information
Region (hg38): X:134373288-134428791
Previous symbols: [ "BFLS", "BORJ" ]
Links
Phenotypes
GenCC
Source:
- Borjeson-Forssman-Lehmann syndrome (Definitive), mode of inheritance: XLR
- Borjeson-Forssman-Lehmann syndrome (Strong), mode of inheritance: XL
- Borjeson-Forssman-Lehmann syndrome (Supportive), mode of inheritance: XL
- Borjeson-Forssman-Lehmann syndrome (Strong), mode of inheritance: XL
- Borjeson-Forssman-Lehmann syndrome (Definitive), mode of inheritance: XL
- Borjeson-Forssman-Lehmann syndrome (Definitive), mode of inheritance: XL
- Borjeson-Forssman-Lehmann syndrome (Definitive), mode of inheritance: XL
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Borjeson-Forssman-Lehmann syndrome | XL | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Endocrine; Musculoskeletal; Neurologic | 13871358; 4465467; 12415272; 15241480; 14756673; 15994862; 16912705; 19264739; 22190899; 23906836 |
ClinVar
This is a list of variants' phenotypes submitted to
- Borjeson-Forssman-Lehmann syndrome (12 variants)
- not provided (8 variants)
- Inborn genetic diseases (4 variants)
- Hereditary spastic paraplegia 4 (1 variants)
- See cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PHF6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 28 | 31 | ||||
missense | 47 | 57 | ||||
nonsense | 10 | 13 | ||||
start loss | 2 | |||||
frameshift | 5 | |||||
inframe indel | 6 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 4 | 4 | 1 | 9 | ||
non coding | 24 | 12 | 36 | |||
Total | 18 | 13 | 54 | 55 | 14 |
Variants in PHF6
This is a list of pathogenic ClinVar variants found in the PHF6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-134373472-G-A | Borjeson-Forssman-Lehmann syndrome | Uncertain significance (Jun 23, 2021) | ||
X-134373475-C-T | not specified | Likely benign (Feb 12, 2016) | ||
X-134377233-TTATC-T | Likely benign (Jul 12, 2019) | |||
X-134377619-T-C | Borjeson-Forssman-Lehmann syndrome • Hereditary spastic paraplegia 4 | Pathogenic (Jul 22, 2022) | ||
X-134377620-G-T | Pathogenic (Jul 02, 2012) | |||
X-134377626-C-T | PHF6-related disorder | Likely benign (Jun 18, 2021) | ||
X-134377638-GA-G | Hirsutism;Intellectual disability | Pathogenic (Dec 03, 2018) | ||
X-134377638-G-GA | Borjeson-Forssman-Lehmann syndrome | Pathogenic (Mar 01, 2006) | ||
X-134377639-A-T | Borjeson-Forssman-Lehmann syndrome | Pathogenic (Dec 01, 2002) | ||
X-134377641-A-G | PHF6-related disorder | Likely benign (Dec 17, 2019) | ||
X-134377644-A-AGG | Borjeson-Forssman-Lehmann syndrome | Pathogenic (Dec 09, 2017) | ||
X-134377656-A-G | PHF6-related disorder | Likely benign (Nov 23, 2022) | ||
X-134377661-G-A | Borjeson-Forssman-Lehmann syndrome | Uncertain significance (Jun 22, 2023) | ||
X-134377665-A-G | PHF6-related disorder | Likely benign (Sep 21, 2022) | ||
X-134377679-A-C | Uncertain significance (May 02, 2024) | |||
X-134377682-C-A | Borjeson-Forssman-Lehmann syndrome | Likely pathogenic (Dec 09, 2016) | ||
X-134377688-G-C | Inborn genetic diseases | Uncertain significance (Nov 03, 2023) | ||
X-134377694-A-T | Uncertain significance (Jun 20, 2022) | |||
X-134377701-T-C | Borjeson-Forssman-Lehmann syndrome | Likely benign (Jul 30, 2022) | ||
X-134377702-G-T | Pathogenic (Nov 03, 2021) | |||
X-134377703-G-C | Borjeson-Forssman-Lehmann syndrome | Uncertain significance (Sep 27, 2020) | ||
X-134377705-C-T | Pathogenic (Dec 06, 2022) | |||
X-134377706-A-G | Borjeson-Forssman-Lehmann syndrome | Uncertain significance (Jun 28, 2022) | ||
X-134377728-GA-G | Borjeson-Forssman-Lehmann syndrome | Uncertain significance (Dec 31, 2016) | ||
X-134377731-G-T | Uncertain significance (Jan 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PHF6 | protein_coding | protein_coding | ENST00000332070 | 9 | 55538 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.998 | 0.00216 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.28 | 57 | 130 | 0.437 | 0.00000914 | 2412 |
Missense in Polyphen | 5 | 52.447 | 0.095334 | 993 | ||
Synonymous | -0.502 | 48 | 43.8 | 1.10 | 0.00000300 | 645 |
Loss of Function | 3.93 | 0 | 18.0 | 0.00 | 0.00000173 | 281 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional regulator that associates with ribosomal RNA promoters and suppresses ribosomal RNA (rRNA) transcription. {ECO:0000269|PubMed:23229552}.;
- Disease
- DISEASE: Boerjeson-Forssman-Lehmann syndrome (BFLS) [MIM:301900]: A X-linked recessive disorder characterized by moderate to severe mental retardation, epilepsy, hypogonadism, hypometabolism, obesity with marked gynecomastia, swelling of subcutaneous tissue of the face, narrow palpebral fissure and large but not deformed ears. {ECO:0000269|PubMed:12415272, ECO:0000269|PubMed:23229552, ECO:0000269|PubMed:23906836}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Mesodermal Commitment Pathway
(Consensus)
Recessive Scores
- pRec
- 0.163
Intolerance Scores
- loftool
- 0.142
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 51.04
Haploinsufficiency Scores
- pHI
- 0.750
- hipred
- Y
- hipred_score
- 0.728
- ghis
- 0.719
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Phf6
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;blastocyst hatching
- Cellular component
- condensed chromosome kinetochore;nucleus;nucleoplasm;nucleolus
- Molecular function
- DNA-binding transcription repressor activity, RNA polymerase II-specific;RNA binding;protein binding;tubulin binding;enzyme binding;histone binding;histone deacetylase binding;ribonucleoprotein complex binding;sequence-specific DNA binding;metal ion binding;phosphoprotein binding;scaffold protein binding